In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis (PrEP) program effectiveness using routine implementation data. More at: www.consultant360.com/infectious-diseases.

In this podcast, Julian Bailes, MD, discusses traumatic brain injury, including mild traumatic brain injury (concussion) as well as chronic traumatic encephalopathy. More at: www.consultant360.com/neurology.

In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the financial barriers to antiretroviral therapy adherence. More at: www.consultant360.com/infectious-diseases.

In this podcast, Robert Giugliano, MD, SM, discusses his latest analysis of IMPROVE-IT data, which compared simvastatin-ezetimibe combination therapy with simvastatin monotherapy among patients aged 75 years or older who had had acute coronary syndrome. He also explains which patient groups benefitted the most from ezetimibe add-on therapy. More at: www.consultant360.com/cardiology.

Amit Etkin, MD, PhD, of Stanford University and Alto Neuroscience, discusses a recent study examining the use of EEG as a tool in depression treatment. More at: bit.ly/DepressionCare360.

In this podcast, Arun Jose, MD, from the University of Cincinnati, discusses his team's research on the outcomes of anticoagulation therapy with vitamin K antagonists among patients with pulmonary arterial hypertension. More at: www.consultant360.com/pulmonology.

In this podcast, Dr Cennimo discusses what clinicians should keep in mind during peak season for respiratory syncytial virus. For more podcasts like this, visit www.consultant360.com.

In this podcast, Lucia Novak names 5 key takeaways from the American Diabetes Association's updated Standards of Medical Care in Diabetes for 2020. For more podcasts like this, visit www.consultant360.com/endocrinology.

In this podcast, Brian King, PhD, MPH, discusses his team's latest research on the prevalence of and risk factors for rehospitalization and death after discharge of patients with e-cigarette and vaping-related lung injury (EVALI), as well as comments on the current EVALI epidemic in the United States. More at: www.consultant360.com/pulmonology.

In this podcast, Florian Krammer, PhD, discusses his team's proof-of-principle trial for a new universal influenza vaccine, as well as how close we are to a universal influenza vaccine. More at: www.consultant360.com/infectious-diseases.